A longitudinal investigation of Aβ, anxiety, depression, and mild cognitive impairment.


Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
10 2022
Historique:
revised: 11 04 2021
received: 28 01 2021
accepted: 09 06 2021
pubmed: 9 12 2021
medline: 21 10 2022
entrez: 8 12 2021
Statut: ppublish

Résumé

We investigated the longitudinal relationship between cortical amyloid deposition, anxiety, and depression and the risk of incident mild cognitive impairment (MCI). We followed 1440 community-dwelling, cognitively unimpaired individuals aged ≥ 50 years for a median of 5.5 years. Clinical anxiety and depression were assessed using Beck Anxiety and Depression Inventories (BAI, BDI-II). Cortical amyloid beta (Aβ) was measured by Pittsburgh compound B positron emission tomography (PiB-PET) and elevated deposition (PiB+) was defined as standardized uptake value ratio ≥ 1.48. We calculated Cox proportional hazards models with age as the time scale, adjusted for sex, education, and medical comorbidity. Cortical Aβ deposition (PiB+) independent of anxiety (BAI ≥ 10) or depression (BDI-II ≥ 13) increased the risk of MCI. There was a significant additive interaction between PiB+ and anxiety (joint effect hazard ratio 6.77; 95% confidence interval 3.58-12.79; P = .031) that is, being PiB+ and having anxiety further amplified the risk of MCI. Anxiety modified the association between PiB+ and incident MCI.

Identifiants

pubmed: 34877794
doi: 10.1002/alz.12504
pmc: PMC9174347
mid: NIHMS1746332
doi:

Substances chimiques

Amyloid beta-Peptides 0
Aniline Compounds 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1824-1831

Subventions

Organisme : NIA NIH HHS
ID : R01 AG057708
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG006786
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG016574
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG034676
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG011378
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG041851
Pays : United States
Organisme : NIMH NIH HHS
ID : K01 MH068351
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS097495
Pays : United States

Informations de copyright

© 2021 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.

Références

Am J Geriatr Psychiatry. 2013 Jul;21(7):685-95
pubmed: 23567400
Int Psychogeriatr. 2018 Feb;30(2):245-251
pubmed: 29198244
Neurodegener Dis. 2012;10(1-4):141-4
pubmed: 22301812
J Clin Epidemiol. 1992 Jun;45(6):613-9
pubmed: 1607900
Am J Geriatr Psychiatry. 2016 Nov;24(11):1095-1104
pubmed: 27426238
Biol Psychiatry. 2000 Aug 15;48(4):301-9
pubmed: 10960161
Am J Geriatr Psychiatry. 2016 Feb;24(2):117-25
pubmed: 26209222
Arch Neurol. 1991 Jul;48(7):725-8
pubmed: 1859300
J Nucl Med. 2009 Jun;50(6):878-86
pubmed: 19443597
Mayo Clin Proc. 2012 Feb;87(2):151-60
pubmed: 22305027
Neurology. 2012 May 15;78(20):1576-82
pubmed: 22551733
Ann Neurol. 2004 Mar;55(3):306-19
pubmed: 14991808
Alzheimers Dement. 2018 Apr;14(4):535-562
pubmed: 29653606
JAMA Neurol. 2018 Aug 1;75(8):970-979
pubmed: 29710225
Acta Neuropathol. 2013 Nov;126(5):643-57
pubmed: 24100688
Alzheimers Dement. 2015 Jan;11(1):1-15.e1-4
pubmed: 25443857
Am J Epidemiol. 2011 May 1;173(9):1059-68
pubmed: 21430193
J Intern Med. 2004 Sep;256(3):183-94
pubmed: 15324362
Am J Psychiatry. 2018 Jun 1;175(6):530-537
pubmed: 29325447
Ann Neurol. 2010 Jan;67(1):122-31
pubmed: 20186853
Neurology. 2015 Mar 3;84(9):935-43
pubmed: 25653291
Qual Life Res. 2019 May;28(5):1111-1118
pubmed: 30456716
Lancet Neurol. 2013 Apr;12(4):357-67
pubmed: 23477989
Alzheimers Dement. 2022 Oct;18(10):1824-1831
pubmed: 34877794
JAMA Neurol. 2016 Jan;73(1):85-92
pubmed: 26595683
JAMA Netw Open. 2019 Aug 2;2(8):e198964
pubmed: 31397865
Neuroepidemiology. 2008;30(1):58-69
pubmed: 18259084
J Consult Clin Psychol. 1988 Dec;56(6):893-7
pubmed: 3204199
Alzheimers Dement. 2013 Sep;9(5):602-8
pubmed: 23562430
Am J Psychiatry. 2014 May;171(5):572-81
pubmed: 24700290
Brain. 2010 Nov;133(11):3336-48
pubmed: 20935035
JAMA. 2019 Jun 18;321(23):2316-2325
pubmed: 31211344
Alzheimers Dement. 2010 May;6(3):221-9
pubmed: 20451870
JAMA Psychiatry. 2015 Mar;72(3):284-91
pubmed: 25629787
Alzheimers Dement. 2017 Mar;13(3):205-216
pubmed: 27697430
Neurobiol Aging. 2020 Jan;85:74-82
pubmed: 31735378
Hum Brain Mapp. 2009 Nov;30(11):3719-35
pubmed: 19441021
Neurology. 1993 Nov;43(11):2412-4
pubmed: 8232972
Transl Psychiatry. 2019 Mar 28;9(1):123
pubmed: 30923322
Br J Psychiatry. 2018 Nov;213(5):654-660
pubmed: 30339108

Auteurs

Anna Pink (A)

Department of Geriatrics, Paracelsus Medical University, Salzburg, Austria.

Janina Krell-Roesch (J)

Department of Quantitative Health Sciences, Mayo Clinic Rochester, Rochester, Minnesota, USA.
Institute of Sports and Sports Science, Karlsruhe Institute of Technology, Karlsruhe, Germany.

Jeremy A Syrjanen (JA)

Department of Quantitative Health Sciences, Mayo Clinic Rochester, Rochester, Minnesota, USA.

Maria Vassilaki (M)

Department of Quantitative Health Sciences, Mayo Clinic Rochester, Rochester, Minnesota, USA.

Val J Lowe (VJ)

Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.

Prashanthi Vemuri (P)

Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.

Gorazd B Stokin (GB)

International Clinical Research Center/St. Anne Hospital, Brno, Czech Republic.

Teresa J Christianson (TJ)

Department of Quantitative Health Sciences, Mayo Clinic Rochester, Rochester, Minnesota, USA.

Walter K Kremers (WK)

Department of Quantitative Health Sciences, Mayo Clinic Rochester, Rochester, Minnesota, USA.

Clifford R Jack (CR)

Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.

David S Knopman (DS)

Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.

Ronald C Petersen (RC)

Department of Quantitative Health Sciences, Mayo Clinic Rochester, Rochester, Minnesota, USA.
Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.

Yonas E Geda (YE)

Department of Neurology, Barrow Neurological Institute, Phoenix, Arizona, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH